Sinovac Biotech Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Sinovac Biotech current Real Value cannot be determined due to lack of data. The regular price of Sinovac Biotech is $0.0. Our model measures the value of Sinovac Biotech from inspecting the company fundamentals such as Return On Equity of 11.03, operating margin of 15.86 %, and Shares Outstanding of 98.9 M as well as reviewing its technical indicators and probability of bankruptcy.
Sinovac Biotech Total Value Analysis
Sinovac Biotech is at this time anticipated to have company total value of 614.58 M with market capitalization of 460.25 M, debt of 93.13 M, and cash on hands of 176.72 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Sinovac Biotech fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
| 614.58 M | 460.25 M | 93.13 M | 176.72 M |
Sinovac Biotech Investor Information
About 16.0% of the company outstanding shares are owned by corporate insiders. The book value of Sinovac Biotech was at this time reported as 2.83. The company had not issued any dividends in recent years. Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against human infectious diseases in the Peoples Republic of China. The company was founded in 1999 and is based in Beijing, the Peoples Republic of China. Sinovac Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 910 people. To find out more about Sinovac Biotech contact the company at 86 10 8289 0088 or learn more at http://www.sinovacbio.com.Sinovac Biotech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sinovac Biotech has an asset utilization ratio of 105.02 percent. This suggests that the Company is making $1.05 for each dollar of assets. An increasing asset utilization means that Sinovac Biotech is more efficient with each dollar of assets it utilizes for everyday operations.Sinovac Biotech Ownership Allocation
Sinovac Biotech shows a total of 98.9 Million outstanding shares. Sinovac Biotech has 15.89 % of its outstanding shares held by insiders and 23.11 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sinovac Biotech Profitability Analysis
The company reported the last year's revenue of 213.17 M. Total Income to common stockholders was 15.35 M with profit before taxes, overhead, and interest of 213.58 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Sinovac Biotech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Sinovac Biotech and how it compares across the competition.
Sinovac Biotech Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Shares Percent Shares Out | 0.20% | |
| Revenue Growth | -18.30% | |
| Float Shares | 59.43M | |
| Shares Short Prior Month | 199.77k |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Sinovac Stock
If you are still planning to invest in Sinovac Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sinovac Biotech's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |